|
A comparable guideline from the AAO is also included. |
|
Section 2 Clinical features of diabetic retinopathy Section 3 Risk factors Section 4 Screening Section 5 Laser and Lenses Section 6 Management of new vessels at the optic disc (NVD) Section 7 Management of new vessels elsewhere (NVE) Section 8 Management of diabetic maculopathy Section 9 Vitrectomy in diabetic eye disease Section 10 Cataract Section 11 Special management problems Section 12 Counselling for diabetic retinopathy Atlas of diabetic retinopathy Contact lenses for photocoagulation References American Academy of Ophthalmology Guidelines for Diabetic Retinopathy |
|
| Diabetic retinopathy remains the major sight threatening eye disease in the working age population, in the developed world. The WHO/IDF (Europe) has endorsed the St. Vincent Declaration (1990) which embodied the aim of reducing the prevalence of visual handicap by one third by the year 20001. Although physicians and ophthalmologists are actively engaged in applying effective therapies to various forms of retinopathy, there is still disagreement concerning many aspects of the practical management of diabetic patients with retinopathy. These guidelines represent a consensus document outlining the epidemiology, clinical features and treatment of various forms of diabetic retinopathy. In addition, information on risk factors and screening methods for retinopathy is included. Some special problems are discussed in the latter part of the document as well as aspects of counselling for patients at different stages of the disease. The Guidelines are advisory and are not intended as a set of rigid rules, since individual patients will require tailored treatment for their particular condition. However, it is hoped that if used appropriately, they will lead to uniformity in the best management of patients with diabetic retinopathy. | |
|
